Jounce Therapeutics, Inc. - stock earnings
Stock symbol JNCE is outdated, potentially delisted? Maybe it is available on other exchange?
JNCE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | 51.0 million USD | 82.0 million USD |
| 2022Q3 | -31.0 million USD | ? USD |
| 2022Q2 | -33.5 million USD | ? USD |
| 2022Q1 | -37.4 million USD | ? USD |
| 2021Q4 | -30.2 million USD | ? USD |
| 2021Q3 | -30.1 million USD | ? USD |
| 2021Q2 | -4.0 million USD | 25.4 million USD |
| 2021Q1 | -26.5 million USD | 1.5 million USD |
| 2020Q4 | 35.5 million USD | 62.3 million USD |
| 2020Q3 | -24.9 million USD | ? USD |
JNCE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -50.9 million USD | 82.0 million USD |
| 2021 | -90.9 million USD | 26.9 million USD |
| 2020 | -43.8 million USD | 62.3 million USD |
| 2019 | 56.8 million USD | 147.9 million USD |
| 2018 | -27.4 million USD | 65.2 million USD |
| 2017 | -16.4 million USD | 71.6 million USD |
JNCE
Price: $1.88
52 week price:
Earnings Per Share: -1.03 USD
P/E Ratio: -2.45
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 291098
Ebitda: -3.5 millionMarket Capitalization: 101.6 million